13 Best Genomics Stocks To Buy Now
Before talking about the best genomics stocks, it is important to understand what the term actually means.
Crispr Therapeutics Ag (CRSP)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
5 Most Promising Gene Therapy Companies to Watch
Krystal Biotech, Inc. (NASDAQ:KRYS)'s latest quarter saw the firm beat analyst estimates, as it posted -$0.17 in earnings per share for its third fiscal quarter.
5 Biggest Genomics Companies In The World
In this article, we will discuss the 5 Biggest Genomics Companies In The World.
ARK Invest Stock Portfolio: Top 10 Picks
ARK Investment Management’s Cathie Wood wrote an open letter to the central bank on October 10, saying that the Federal Reserve is mistaken in its aggressive stance against inflation.
Top 12 From Cathie Wood's Q2 Portfolio
In this article, we will be taking a look at the top 12 from Cathie Wood's Q2 portfolio.
Cathie Wood Dumped These 3 Stocks in July
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a Massachusetts-based genome editing company that develops novel genomic medicines using CRISPR/Cas9 technology for the treatment of ocular diseases.
Cathie Wood's Fund Starts to Rebound: 10 Stocks to Watch
In this article, we discuss 10 stocks to watch as Cathie Wood's fund starts to rebound.
Analysts Just Decreased Price Targets of These 5 Stocks
In this article, we discuss the 5 stocks that recently received price-target cuts from analysts.
Hedge Funds Love These 10 Undervalued Mid-Cap Stocks
In this article, we discuss the 10 undervalued mid-cap stocks that hedge funds love.
Cathie Wood's 5 Stock Picks for the Next 5 Years
In this article, we discuss Cathie Wood's 5 stock picks for the next 5 years.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
